4.5 C
London
Saturday, November 21, 2026

Genetics Matter: Study Reveals 25% Misprescriptions in Meds

Your genetic makeup could be a crucial element that your healthcare provider overlooks when prescribing medications.

According to a study released on Wednesday in Science Translational Medicine, almost 25% of participants received prescriptions that might have warranted a different medication or dosage tailored to their genetic profile.

Conducted by a team from the University of Pittsburgh, the research focused on 16 genes that influence the body’s reactions to various drugs.

The analysis examined DNA samples from 98,590 individuals enrolled in the National Institutes of Health’s All of Us Research Program, correlating these samples with available medical records.

Each participant had at least one significant genetic variation that could alter their response to specific medications, with the average individual showing nine such variations. Among those who had both genetic and clinical data, 24.4% had been prescribed at least one medication that guidelines suggested should have been substituted for another drug or dosage based on their genetic profile.

Nonetheless, the research did not ascertain if patients faced side effects or if their medications were less effective due to their genetic characteristics.

Dr. Philip Empey, the study’s senior author and an associate professor at the University of Pittsburgh’s pharmacy school, believes that understanding a patient’s genetic background could minimize the trial-and-error approach often seen in prescribing medicine.

“Any advancements we can make to better anticipate, from the outset, what medications and dosages will be most effective can greatly reduce that trial-and-error process,” he stated.

A woman in a medical mask sorts pills on a counter.

A pharmacist organizing medications in a Vancouver pharmacy in October 2022. Genetic variations can influence how patients respond to particular medications, potentially necessitating dosage adjustments or alternative prescriptions. (Darryl Dyck/The Canadian Press)

Choosing the Right Medication

Among the most frequently prescribed medications for participants whose genetic profiles could suggest different treatments were omeprazole and pantoprazole for acid reflux, along with atorvastatin for cholesterol management.

Empey notes that certain genetic variations may heighten the risk of muscle-related issues when patients take statins like atorvastatin, which are intended to lower the chances of heart attacks or strokes.

Such insights could aid healthcare providers in opting for alternative medications or modifying treatment plans.

“It enables clinicians to make more informed choices, suggesting, ‘Perhaps that cholesterol medication isn’t the best option. Let’s start with a lower dose, or monitor specific toxicities more closely,'” Empey explained.

In other cases, the implications can be more severe.

Experts consulted by CBC News indicate that genetic testing can assist in pinpointing patients who may not respond effectively to clopidogrel (Plavix), a medication used to prevent blood clots following cardiac stenting, allowing healthcare providers to prescribe a different drug.

A man in a suit and tie sits in a laboratory.

Dr. James Kennedy, the head of the Tanenbaum Centre for Pharmacogenetics at Toronto’s Centre for Addiction and Mental Health, emphasizes that while genetic testing can guide medication choices, it is vital to consider other factors, such as diet, lifestyle, and existing medications. (CBC)

A Guideline, Not a Guarantee

Dr. James Kennedy remarked that the findings of the study were expected, but he was particularly impressed by the genetic diversity among participants, especially those of African descent.

Kennedy’s team has conducted genetic testing for about 11,000 patients, many of whom had previously tried several antidepressants without finding satisfactory relief.

He notes that roughly 8 to 10% of individuals metabolize certain commonly prescribed antidepressants at an unusually slow rate, leading to drug accumulation and potential side effects.

Kennedy believes genetic testing is particularly beneficial for patients who have faced challenges with multiple medications.

However, he cautions that DNA testing alone does not guarantee how a patient will react to a specific medication. Other medications being taken, smoking habits, and diet also need to be factored in.

“We provide a blueprint of tendencies and then engage in a discussion about all the other factors to consider before reaching a final decision,” he explained.

A 2023 European clinical trial mentioned within the study indicated that conducting genetic tests prior to prescribing specific medications helped decrease adverse drug reactions. However, implementing routine testing in Canada remains a challenge.

A person in purple gloves points to a small plastic test tube.

A researcher at the University of Calgary displays a diagnostic kit for identifying genetic variations in February 2024. While such testing could assist doctors in customizing medications for individual patients, the costs and logistical issues have hindered its broader implementation in Canada. (Jeff McIntosh/The Canadian Press)

Challenges in Widespread Testing in Canada

Toronto cardiologist Dr. Jacob Udell expressed admiration for the study, particularly its diverse genetic participant pool, yet noted that few healthcare providers in Canada or the U.S. routinely test patients for genetic variations that could influence drug metabolism.

“It’s not something that frontline clinicians typically prioritize,” he remarked.

Udell explained that for many conditions, doctors can prescribe medications, observe the patient’s response, and adjust as needed, often without significant repercussions. This approach can be more practical than routinely screening for genetic variations.

He also questioned if widespread testing should be prioritized in a healthcare system like Canada’s that is currently struggling to offer more fundamental services.

“We’re primarily focused on ensuring everyone has a family doctor,” he stated.

In addition to the testing expenses, Udell mentioned that healthcare providers would require access to genetic test results and the expertise to interpret them.

Empey concurred that integrating genetic testing into standard practice would demand significant investments in training, infrastructure, and systems for sharing results among healthcare professionals.

“The scientific basis is solid for many medications. The challenge of implementation then shifts to economic, procedural, and educational concerns,” he added.

For the time being, Empey advises patients to consult with their doctors or pharmacists about the potential benefits of genetic testing and to share any relevant results.

Udell cautioned that private testing may become more prevalent among those who can afford it, “but this won’t assist those who cannot cover the costs of testing.”

Source

Latest news
Related news